230 related articles for article (PubMed ID: 30553522)
1. Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy.
Johnston MC; Scott CJ
Drug Discov Today Technol; 2018 Dec; 30():63-69. PubMed ID: 30553522
[TBL] [Abstract][Full Text] [Related]
2. Benefits and challenges of antibody drug conjugates as novel form of chemotherapy.
Fatima SW; Khare SK
J Control Release; 2022 Jan; 341():555-565. PubMed ID: 34906604
[TBL] [Abstract][Full Text] [Related]
3. Antibody-Drug Conjugates for Tumor Targeting-Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins.
Merten H; Brandl F; Plückthun A; Zangemeister-Wittke U
Bioconjug Chem; 2015 Nov; 26(11):2176-85. PubMed ID: 26086208
[TBL] [Abstract][Full Text] [Related]
4. Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment.
Juan A; Cimas FJ; Bravo I; Pandiella A; Ocaña A; Alonso-Moreno C
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825618
[TBL] [Abstract][Full Text] [Related]
5. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.
McCombs JR; Owen SC
AAPS J; 2015 Mar; 17(2):339-51. PubMed ID: 25604608
[TBL] [Abstract][Full Text] [Related]
6. Marine Antibody-Drug Conjugates: Design Strategies and Research Progress.
Wang YJ; Li YY; Liu XY; Lu XL; Cao X; Jiao BH
Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28098746
[TBL] [Abstract][Full Text] [Related]
7. Amanitins and their development as a payload for antibody-drug conjugates.
Pahl A; Lutz C; Hechler T
Drug Discov Today Technol; 2018 Dec; 30():85-89. PubMed ID: 30553524
[TBL] [Abstract][Full Text] [Related]
8. Use of pyrrolobenzodiazepines and related covalent-binding DNA-interactive molecules as ADC payloads: Is mechanism related to systemic toxicity?
Jackson PJM; Kay S; Pysz I; Thurston DE
Drug Discov Today Technol; 2018 Dec; 30():71-83. PubMed ID: 30553523
[TBL] [Abstract][Full Text] [Related]
9. Antibody drug conjugates.
Bakhtiar R
Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710
[TBL] [Abstract][Full Text] [Related]
10. Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery.
Richards DA
Drug Discov Today Technol; 2018 Dec; 30():35-46. PubMed ID: 30553519
[TBL] [Abstract][Full Text] [Related]
11. Miniaturised 'antibody'-drug conjugates for solid tumours?
Deonarain MP
Drug Discov Today Technol; 2018 Dec; 30():47-53. PubMed ID: 30553520
[TBL] [Abstract][Full Text] [Related]
12. Toward aplyronine payloads for antibody-drug conjugates: total synthesis of aplyronines A and D.
AnŽiček N; Williams S; Housden MP; Paterson I
Org Biomol Chem; 2018 Feb; 16(8):1343-1350. PubMed ID: 29393939
[TBL] [Abstract][Full Text] [Related]
13. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
Tsuchikama K; An Z
Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
[TBL] [Abstract][Full Text] [Related]
14. Total Synthesis in Search of Potent Antibody-Drug Conjugate Payloads. From the Fundamentals to the Translational.
Nicolaou KC; Rigol S
Acc Chem Res; 2019 Jan; 52(1):127-139. PubMed ID: 30575399
[TBL] [Abstract][Full Text] [Related]
15. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
Chen H; Lin Z; Arnst KE; Miller DD; Li W
Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044
[TBL] [Abstract][Full Text] [Related]
16. Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.
Vezina HE; Cotreau M; Han TH; Gupta M
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S11-S25. PubMed ID: 28921650
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985.
Elgersma RC; Coumans RG; Huijbregts T; Menge WM; Joosten JA; Spijker HJ; de Groot FM; van der Lee MM; Ubink R; van den Dobbelsteen DJ; Egging DF; Dokter WH; Verheijden GF; Lemmens JM; Timmers CM; Beusker PH
Mol Pharm; 2015 Jun; 12(6):1813-35. PubMed ID: 25635711
[TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic.
Stagg NJ; Shen BQ; Brunstein F; Li C; Kamath AV; Zhong F; Schutten M; Fine BM
Regul Toxicol Pharmacol; 2016 Dec; 82():1-13. PubMed ID: 27773754
[TBL] [Abstract][Full Text] [Related]
19. Peptide-Drug Conjugate: A Novel Drug Design Approach.
Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
Singh SK; Luisi DL; Pak RH
Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
